Clinical Trial Update: Antireflux Ablation of the Cardia Mucosa vs Placebo for the Treatment of Gastroesophageal Reflux Disease [NA]

View source ↗

Summary

A completed clinical trial evaluating antireflux ablation of the cardia mucosa versus placebo for gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: Gastroesophageal Reflux Disease | NA | Status: COMPLETED